Clinical Sexologist and Therapist Joins Krongrad Institute
Rhonda Fine PhD ARNP Many factors can adversely affect sexual performance. Physical disability illness, obesity, medications, aging, stress, grief, emotional distress and relationship conflicts may all...
View ArticleMusic Therapy Helps Relieve Anxiety of Cancer
Music “has Charms to sooth a savage Breast,” wrote playwright William Congreve, “To soften Rocks, or bend a knotted Oak.” But can it soothe those mired in the grief, confusion and pain of cancer...
View ArticleFosamax Linked to Esophageal Cancer
Diane Wysowski of the FDA’s division of drug risk assessment says researchers should check into potential links between oral bisphosphonate drugs and cancer of the esophagus. Merck’s oral osteoporosis...
View ArticleBisphosphonate Side Effects and a New Clinical Trial
Recent stories on bisphosphonate side effects might be signaling the advent of a new, superior drug, but will Halozyme’s rHuPH20 enzyme solve the problem of jaw necrosis? Drug development companies...
View ArticleProvenge Significantly Extends Survival of Men With Advanced Prostate Cancer,...
Dendreon’s prostate cancer vaccine significantly prolonged the overall survival among 500 men with advanced, metastic prostate cancer compared to a placebo, the company said Tuesday. Results were...
View ArticleInvestor Interviews Hy Levitsky M.D. on Provenge
A four part interview with Hy Levitsky M.D., professor of oncology and tumor immunology at Johns Hopkins Medical School and co-inventor GVAX anti-cancer vaccine, is posted on Dendreon Investor Village...
View ArticleIs Proton Therapy On Pres. Obama’s Health-Care Hatchet List?
Proton beam therapy for prostate cancer, a treatment that attracts more than an average numbers of engineers, scientists and pilots, is coming under intense scrutiny from reporters who expect it to be...
View ArticleDenosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Androgen-deprivation therapy is well-established for treating prostate cancer but is associated with bone loss and an increased risk of fracture. Matthew R. Smith and an international team investigated...
View ArticleWhat your oncologists can learn about prostate cancer this fall
For a glimpse into what your oncologist can learn about prostate cancer this fall check out the agenda for this October 31, 2009 conference. Unfortunately, for prostate cancer this learning session...
View ArticleDisparities in cancer care reflect hospital resources, U-M study finds
If you are a cancer patient, whatever your race — whether you are African American, Hispanic or white — in the USA you would be well advised to seek treatment at a hospital that treats mostly white...
View ArticleZytiga Lowers PSA in men with high-risk prostate cancer, at a cost in...
Prostate cancer survivors during the era 2005-2013, as you'll see from our tag cloud (sidebar), were bombarded by Dendreon's controversial campaign to speed FDA approval of its immunotherapy vaccine...
View Article
